Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan

Published:2023-05-08 Issue:8 Volume:25 Page:2419-2422
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Smeijer J. David¹^ORCID,Kohan Donald E.²^ORCID,de Zeeuw Dick¹,Heerspink Hiddo J. L.¹^ORCID

Affiliation:

1. Department of Clinical Pharmacy and Pharmacology University of Groningen Groningen the Netherlands

2. Division of Nephrology University of Utah Health Salt Lake City Utah USA

Funder

Innovative Medicines Initiative

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference10 articles.

1. Endothelin and endothelin antagonists in chronic kidney disease

2. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

3. Regulation of Blood Pressure and Salt Homeostasis by Endothelin

4. Myocardial, Smooth Muscle, Nephron, and Collecting Duct Gene Targeting Reveals the Organ Sites of Endothelin A Receptor Antagonist Fluid Retention

5. Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP